Our analysis of the NOD2, ATG16L1 and RAC1 polymorphisms was not significantly associated with progressive liver disease or frequent episodes of sepsis, ICU admissions, chronic TPN use and need for transplantation. This evidence concerns the gene NOD2 and liver disorder.